N. Mort

Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.

M. Vieth, R. Campbell, B. Anderson, 2003, Journal of medicinal chemistry.

Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.

R. Campbell, B. Anderson, Faming Zhang, 2004, Bioorganic & medicinal chemistry letters.

Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists.

C. Nichols, F. Haviv, G. Bammert, 1993, Journal of medicinal chemistry.

Structure-activity relationships of positions 7, 8, and 9 in LHRH antagonists with respect to histamine release, LH, and testosterone suppressions

J. Greer, F. Haviv, G. Bammert, 1994 .

The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonists.

M. R. Holst, C. Nichols, F. Haviv, 1993, Journal of medicinal chemistry.

Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.

S. A. Watkins, H. Brooks, J. Yingling, 2005, Biochemistry.